Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
2020 · Science Translational Medicine · 200 citations
https://doi.org/10.1126/scitranslmed.aaz0463
M
Michael P. Rettig
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
319
Papers
7.3K
Citations
39
h-index
91
i10-index
Michael P. Rettig is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & CAR-T cell therapy research & Hematopoietic Stem Cell Transplantation. The author has an h-index of 39, co-authored 272 publications.
ORCID: 0000-0002-1091-0564Papers by this author
worksCo-evolution of tumor and immune cells during progression of multiple myeloma
2021 · Nature Communications · 135 citations
https://doi.org/10.1038/s41467-021-22804-x
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
2022 · Nature Communications · 86 citations
https://doi.org/10.1038/s41467-022-30860-0
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
2023 · Nature Medicine · 71 citations
https://doi.org/10.1038/s41591-023-02273-z
CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells
2022 · Leukemia · 53 citations
https://doi.org/10.1038/s41375-022-01559-4
Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
2023 · JACC Basic to Translational Science · 33 citations
https://doi.org/10.1016/j.jacbts.2022.09.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat